Breast cancer:

Indications for: ARIMIDEX

In postmenopausal women: adjuvant treatment of hormone receptor-positive early breast cancer; first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer; advanced breast cancer with disease progression after tamoxifen therapy.

Adult Dosage:

1mg once daily. Advanced disease: continue until tumor progression.

Children Dosage:

Not applicable.

ARIMIDEX Contraindications:

Women who are or may become pregnant. Pregnancy (Cat.X).

ARIMIDEX Warnings/Precautions:

Pre-existing ischemic heart disease. Severe hepatic impairment. Monitor bone mineral density, cholesterol. Nursing mothers: not recommended.

ARIMIDEX Classification:

Aromatase inhibitor.

ARIMIDEX Interactions:

Antagonized by tamoxifen, estrogens; do not give concomitantly.

Adverse Reactions:

Hot flashes, asthenia, arthritis, pain, arthralgia, pharyngitis, hypertension, depression, nausea, vomiting, rash, osteoporosis, fractures, back pain, insomnia, headache, peripheral edema, lymphedema, dyspnea, dizziness, paresthesia, vaginal bleeding, cough, hypercholesterolemia.

How Supplied: